S
Suellen P. Ferraris
Researcher at University of Kentucky
Publications - 23
Citations - 2034
Suellen P. Ferraris is an academic researcher from University of Kentucky. The author has contributed to research in topics: Thrombin receptor & Platelet activation. The author has an hindex of 13, co-authored 23 publications receiving 1965 citations. Previous affiliations of Suellen P. Ferraris include Letterman Army Medical Center & Albany Medical College.
Papers
More filters
Journal ArticleDOI
Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline.
Victor A. Ferraris,Suellen P. Ferraris,Sibu P. Saha,Eugene A. Hessel,Constance K. Haan,B. David Royston,Charles R. Bridges,Robert S.D. Higgins,George J. Despotis,Jeremiah R. Brown,Bruce D. Spiess,Linda Shore-Lesserson,Mark Stafford-Smith,C. David Mazer,Elliott Bennett-Guerrero,Steven E. Hill,Simon C. Body +16 more
TL;DR: Based on available evidence, institution-specific protocols should screen for high- risk patients, as blood conservation interventions are likely to be most productive for this high-risk subset of patients.
Journal ArticleDOI
Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting
Victor A. Ferraris,Suellen P. Ferraris,Suellen P. Ferraris,Frederick C. Lough,Frederick C. Lough,William R. Berry,William R. Berry +6 more
TL;DR: It is concluded that aspirin ingestion increases postoperative blood loss and transfusion requirements, and it is recommended to discontinuation of aspirin therapy before cardiac procedures.
Journal ArticleDOI
Transitioning patients from cangrelor to clopidogrel: pharmacodynamic evidence of a competitive effect.
Steven R. Steinhubl,Jennifer J. Oh,Julie H. Oestreich,Suellen P. Ferraris,Richard Charnigo,Wendell S. Akers +5 more
TL;DR: To achieve sustained platelet P2Y12 inhibition in patients treated with cangrelor, clopidogrel administration should be started when the cang Relor infusion is terminated.
Journal ArticleDOI
Pharmacokinetics and pharmacodynamics of a bolus and infusion of cangrelor: a direct, parenteral P2Y12 receptor antagonist.
Wendell S. Akers,Jennifer J. Oh,Julie H. Oestreich,Suellen P. Ferraris,Mary Wethington,Steven R. Steinhubl +5 more
TL;DR: High‐dose cangrelor is more consistent and demonstrates a greater level of inhibition on adenosine diphosphate—induced P‐selectin expression; however, no significant differences are observed between the 2 dosing regimens with regard to platelet aggregation or time to recovery of platelet function.
Journal ArticleDOI
The Society of Thoracic Surgeons Practice Guideline Series: Aspirin and Other Antiplatelet Agents During Operative Coronary Revascularization (Executive Summary)*
Victor A. Ferraris,Suellen P. Ferraris,David J. Moliterno,Philip Camp,Jeanine M. Walenga,Harry L. Messmore,Walter Jeske,Fred H. Edwards,David Royston,David M. Shahian,Eric D. Peterson,Charles R. Bridges,George J. Despotis +12 more
TL;DR: This list of hospitals and clinics in the United States and abroad that provide medical care to seriously ill and injured patients is compiled.